Vivaldi Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Sell |
15,661
-4,463
| -22% | -$61.1K | 0.03% | 273 |
|
|
2025
Q1 | $223K | Hold |
20,124
| – | – | 0.04% | 247 |
|
|
2024
Q4 | $211K | Hold |
20,124
| – | – | 0.03% | 260 |
|
|
2024
Q3 | $256K | Hold |
20,124
| – | – | 0.07% | 178 |
|
|
2024
Q2 | $338K | Hold |
20,124
| – | – | 0.1% | 155 |
|
|
2024
Q1 | $256K | Buy |
20,124
+3,663
| +22% | +$46.7K | 0.07% | 182 |
|
|
2023
Q4 | $309K | Hold |
16,461
| – | – | 0.09% | 162 |
|
|
2023
Q3 | $231K | Buy |
16,461
+4,961
| +43% | +$69.5K | 0.08% | 168 |
|
|
2023
Q2 | $119K | Buy |
+11,500
| New | +$119K | 0.04% | 195 |
|
|
2021
Q4 | – | Sell |
-16,650
| Closed | -$280K | – | 235 |
|
|
2021
Q3 | $280K | Buy |
+16,650
| New | +$280K | 0.06% | 185 |
|
|
2020
Q4 | – | Sell |
-10,000
| Closed | -$233K | – | 326 |
|
|
2020
Q3 | $233K | Sell |
10,000
-1,000
| -9% | -$23.3K | 0.05% | 221 |
|
|
2020
Q2 | $255K | Buy |
+11,000
| New | +$255K | 0.05% | 213 |
|